Monkeypox vaccine attracts interest for Bavarian as virus spreads
Bavarian, which signed a supply contract with an unnamed European country last week, reports it is in dialog with several countries, some yet to be affected, concerning the firm’s monkeypox vaccine.
By Christian Wienberg, bloomberg
Bavarian Nordic A/S, the only maker of an approved vaccine to prevent monkeypox, is in talks to supply several countries that have identified cases of the viral infection.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Bavarian's market value up USD 1bn over three days
For subscribers
Smallpox projects send stocks soaring
For subscribers
